We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Kumar - Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide-Based Initial Therapy
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota, USA
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles